BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Money funds | 37.92%35B | -2.77%24.72B | 3.96%23.69B | -7.25%23.35B | 14.99%25.38B | -0.65%25.42B | -2.92%22.79B | 13.86%25.18B | 18.32%22.07B | 0.78%25.59B |
Deposit in interbank | -17.55%1.92B | 22.96%2.59B | 14.35%3.41B | -9.90%2.21B | 2.88%2.32B | -3.56%2.1B | -11.06%2.98B | 15.71%2.45B | -27.71%2.26B | -39.84%2.18B |
Lending capital | 25.35%3.85B | 19.30%5.26B | 61.78%5.41B | 102.24%3.83B | 37.52%3.07B | 313.41%4.41B | 216.97%3.34B | 81.05%1.89B | 4,872.49%2.23B | 1,324.63%1.07B |
Transactional financial assets | 33.67%36.77B | 32.01%37.94B | 12.51%35.2B | 16.50%34.29B | -0.60%27.51B | 10.61%28.74B | 48.59%31.28B | 40.00%29.43B | 39.70%27.68B | 32.32%25.99B |
Derivative assets | ---- | ---- | ---- | ---- | --44K | --144K | ---- | ---- | ---- | ---- |
Bought sellback assets | 35.81%20.86B | -9.06%17.33B | -14.69%14.27B | 48.21%17.45B | 98.84%15.36B | 240.05%19.06B | 463.43%16.73B | 60.27%11.77B | -29.89%7.73B | -13.07%5.61B |
Loan and advance | 23.07%260.02B | 16.30%230.27B | 11.43%213.76B | 7.64%208.94B | 10.19%211.27B | 6.82%198B | 4.55%191.83B | 6.24%194.12B | 6.73%191.73B | 4.75%185.36B |
Debt investment | -7.72%130.24B | -4.99%135.58B | -0.36%138.43B | 5.64%142.33B | 6.53%141.14B | 17.54%142.7B | 18.93%138.93B | 25.79%134.73B | 33.75%132.48B | 26.77%121.41B |
Other debt investment | --21.81B | 298.10%18.04B | --7.02B | --4.28B | ---- | --4.53B | ---- | ---- | ---- | ---- |
Other equity investment | --293.72M | 99.35%300.52M | --289.44M | --198.98M | ---- | --150.75M | ---- | ---- | ---- | ---- |
Long term equity investment | 11.76%2.9B | 13.02%2.81B | 15.05%2.78B | 15.14%2.69B | 14.29%2.59B | 12.49%2.49B | 9.97%2.42B | 136.79%2.34B | 137.00%2.27B | 138.00%2.21B |
Fixed assets | ---- | -7.88%257.31M | ---- | -9.29%260.73M | ---- | -8.10%279.33M | ---- | -8.80%287.42M | ---- | -10.06%303.96M |
Constru in process | ---- | 24.46%13.6M | ---- | 77.98%14.58M | ---- | -36.09%10.92M | ---- | -49.66%8.19M | ---- | -3.27%17.09M |
Intangible assets | -12.94%59.96M | -11.89%64.3M | -19.41%63.14M | -22.26%64.17M | -15.90%68.87M | -8.90%72.98M | -1.33%78.35M | 2.06%82.54M | 4.38%81.88M | -1.54%80.11M |
Deferred tax assets | 18.64%3.77B | 11.83%3.48B | 11.69%3.31B | 11.80%3.18B | 13.32%3.18B | 15.86%3.11B | 17.21%2.96B | 15.72%2.84B | 14.19%2.81B | 12.37%2.68B |
Other assets | -11.03%1.66B | 80.60%1.4B | -6.50%1.52B | 105.33%1.87B | 129.09%1.87B | 7.95%774.85M | 28.47%1.62B | -11.10%911.9M | -23.51%816.75M | -32.92%717.77M |
Total assets | 17.84%519.72B | 11.14%480.37B | 5.49%449.74B | 5.26%445.26B | 6.00%441.06B | 6.50%432.2B | 17.15%426.32B | 19.76%423B | 22.09%416.1B | 17.34%405.84B |
Liabilities | ||||||||||
Borrowing from the central bank | 219.72%23.24B | -33.96%17.99B | -40.92%15.29B | -70.10%5.62B | -53.95%7.27B | 169.14%27.24B | 248.27%25.88B | 162.80%18.79B | 197.98%15.78B | 143.11%10.12B |
Deposit of interbank | -2.96%1.09B | -25.09%1.08B | -9.03%1.11B | -8.76%1.11B | -8.33%1.12B | 27.22%1.44B | -65.14%1.22B | -59.90%1.22B | 23.97%1.22B | 15.50%1.13B |
Deposit | 17.16%359.58B | 9.07%330.01B | 8.73%322.72B | 11.30%319.52B | 6.21%306.92B | 5.17%302.56B | 12.95%296.8B | 11.93%287.07B | 24.24%288.99B | 22.56%287.68B |
Borrowing capital | 3.47%1.84B | 26.58%1.9B | -15.72%1.46B | -33.18%1.46B | -16.80%1.78B | -29.87%1.5B | 8.01%1.74B | 99.10%2.19B | 137.53%2.13B | 42.84%2.14B |
Transactional financial liabilities | 59.67%4.27B | 59.59%4.56B | 112.04%3.64B | 49.21%2.73B | --2.67B | --2.86B | --1.71B | --1.83B | ---- | ---- |
Derivative liabilities | ---- | ---- | ---- | ---- | --60K | --138K | ---- | ---- | ---- | ---- |
Funds from selling out and repurchasing financial assets | ---- | 343.21%297.02M | 62.62%3B | 84.31%12.17B | 174.42%14.96B | -99.26%67.01M | -7.85%1.84B | 44.85%6.6B | -46.06%5.45B | 85.79%9.01B |
Salaries payable | 16.52%530.45M | 18.34%683.82M | -5.28%515.02M | -17.60%486.26M | -16.90%455.24M | -11.10%577.87M | -8.05%543.72M | 3.06%590.11M | -12.90%547.82M | 2.25%650.04M |
Taxs payable | 87.55%552.35M | 95.04%483.84M | -4.63%265.04M | -24.58%220.13M | -13.61%294.51M | 41.36%248.08M | 11.12%277.92M | 16.38%291.86M | -21.44%340.92M | -56.78%175.5M |
Estimate liabilities | -9.55%108.05M | -21.08%138.23M | -5.03%170.8M | 28.87%144.58M | -31.13%119.46M | 2.72%175.15M | -4.05%179.84M | -35.67%112.19M | 11.46%173.45M | 2.25%170.52M |
Bonds payable | 30.91%93.06B | 36.36%86.65B | 4.31%66.25B | -8.28%66.65B | 1.72%71.08B | -1.05%63.54B | 14.99%63.51B | 45.35%72.67B | 16.34%69.88B | -7.24%64.22B |
Absorbing deposits and interbank deposits | 17.08%360.67B | 8.91%331.09B | 8.66%323.83B | 11.22%320.63B | 6.15%308.04B | 5.26%304B | 11.92%298.02B | 11.09%288.29B | 24.24%290.21B | 22.53%288.81B |
Other liabilitise | -41.30%1.44B | 267.37%2.83B | 28.94%2.35B | 105.25%2.8B | 93.51%2.45B | -23.00%771.13M | 50.53%1.82B | 1.65%1.36B | 27.80%1.26B | -21.85%1B |
Total liabilities | 18.70%485.96B | 11.37%446.9B | 5.36%417.04B | 5.13%413.19B | 6.04%409.41B | 6.55%401.28B | 18.13%395.84B | 20.94%393.02B | 23.56%386.08B | 18.33%376.59B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B | 0.00%4.44B |
Capital reserve funds | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B | 0.00%3.69B |
Surplus reserve funds | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B | 0.00%2.6B |
Retained profit | 11.19%17.38B | 11.50%16.66B | 14.16%16.62B | 14.62%16.03B | 11.26%15.63B | 11.62%14.94B | 9.03%14.56B | 9.26%13.99B | 7.82%14.05B | 7.80%13.39B |
Other composite income | -203.54%-115.22M | 334.44%303.77M | -6.23%166.9M | -49.72%126.43M | -53.04%111.28M | -43.48%69.92M | -48.08%177.98M | -20.15%251.48M | 18.47%236.99M | 109.55%123.72M |
Ordinary risk reserve funds | 11.57%5.7B | 11.57%5.7B | 3.50%5.11B | 3.50%5.11B | 3.50%5.11B | 3.50%5.11B | 14.14%4.94B | 14.14%4.94B | 14.14%4.94B | 14.14%4.94B |
Shareholders equity without minority interests | 6.69%33.7B | 8.24%33.4B | 7.31%32.64B | 7.00%32.01B | 5.43%31.58B | 5.74%30.86B | 5.75%30.41B | 6.15%29.91B | 5.89%29.96B | 5.97%29.19B |
Minority interests | -1.92%65.1M | 3.24%67.69M | 4.81%66.09M | 2.68%66.33M | 6.35%66.37M | 5.04%65.57M | -0.21%63.06M | 3.34%64.6M | -0.66%62.41M | 0.24%62.42M |
Total shareholder equity | 6.67%33.76B | 8.23%33.47B | 7.31%32.7B | 6.99%32.07B | 5.44%31.65B | 5.74%30.93B | 5.73%30.47B | 6.14%29.98B | 5.88%30.02B | 5.96%29.25B |
Total liabilities and equity | 17.84%519.72B | 11.14%480.37B | 5.49%449.74B | 5.26%445.26B | 6.00%441.06B | 6.50%432.2B | 17.15%426.32B | 19.76%423B | 22.09%416.1B | 17.34%405.84B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.